Table 1.
T790M Positive | T790M Negative | p value | ||
---|---|---|---|---|
Total number of patients | 69 | 28 | ||
Age (mean ± standard deviation) | 65.2 ± 11.3 | 70.3 ± 11.5 | p = 0.052 | |
Gender | ||||
Male | 22 | 6 | p = 0.30 | |
Female | 47 | 22 | ||
Ethnicity | ||||
Caucasian | 13 | 11 | p = 0.14 | |
Black | 1 | 0 | ||
Asian | 22 | 4 | ||
Hispanic | 5 | 2 | ||
Other | 5 | 0 | ||
Unknown | 23 | 11 | ||
Smoking Status | ||||
Current or Former Smoker | 18 | 4 | p = 0.21 | |
Never Smoker | 51 | 24 | ||
EGFR Mutation | ||||
Exon 19 Deletion | 43 | 15 | p = 0.57 | |
L858R | 20 | 10 | ||
Exon 19 Deletion and L858R | 2 | 0 | ||
Unknown | 4 | 3 | ||
Stage | ||||
IV at Diagnosis | 58 | 25 | p = 0.51 | |
Recurrent | 11 | 3 | ||
Tumor Histology | ||||
Adenocarcinoma | 67 | 26 | p = 0.28 | |
Squamous Cell Carcinoma | 0 | 1 | ||
Adenosquamous Carcinoma | 2 | 1 | ||
Data Analysis | ||||
By RECIST | 51 | 25 | ||
By Medical chart | 18 | 3 | ||
Treated with first-line TKI | 66 | 28 | ||
Treated with TKI rechallenge | 29 | 14 | ||
Treated with chemotherapy | 42 | 18 |